Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Capital Employed (2021 - 2023)

Historic Return on Capital Employed for Terns Pharmaceuticals (TERN) over the last 3 years, with Q3 2023 value amounting to 0.32%.

  • Terns Pharmaceuticals' Return on Capital Employed rose 500.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.28% for FY2022, which is 1200.0% up from last year.
  • Terns Pharmaceuticals' Return on Capital Employed amounted to 0.32% in Q3 2023, which was up 500.0% from 0.26% recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Return on Capital Employed ranged from a high of 0.22% in Q2 2021 and a low of 0.37% during Q2 2022
  • Moreover, its 3-year median value for Return on Capital Employed was 0.3% (2021), whereas its average is 0.29%.
  • In the last 5 years, Terns Pharmaceuticals' Return on Capital Employed crashed by -1500bps in 2022 and then surged by 1100bps in 2023.
  • Over the past 3 years, Terns Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.3% in 2021, then increased by 10bps to 0.27% in 2022, then decreased by -19bps to 0.32% in 2023.
  • Its last three reported values are 0.32% in Q3 2023, 0.26% for Q2 2023, and 0.25% during Q1 2023.